Trials / Recruiting
RecruitingNCT06718569
Pain in Inflammatory Joint Diseases
Advancing the Understanding of Pain Mechanisms in Inflammatory Arthritis Towards Precision Pain Management
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 350 (estimated)
- Sponsor
- Diakonhjemmet Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Our primary objective is to better understand the etiology and consequences of chronic paint by using an explorative approach to identify phenotypes and endotypes of patients with inflammatory joint diseases, with a special focus on central sensitization and cognitive functioning as a key element in chronic pain. We will also examine the risk factors and clinical impact of these factors on pain, disease activity and treatment effects in a longitudinal study of patients with inflammatory joint disesases.
Conditions
- Arthritis
- Arthritis, Juvenile Idiopathic
- Arthritis,Rheumatoid
- Arthritis, Reactive
- Arthritis, Psoriatic
- Spondyloarthritis (SpA)
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Biological or targeted synthetic DMARD | All biological or targeted synthetic DMARDs that are available for treatment of patients with inflammatory joint diseases |
Timeline
- Start date
- 2025-11-11
- Primary completion
- 2027-11-01
- Completion
- 2027-11-01
- First posted
- 2024-12-05
- Last updated
- 2026-04-13
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT06718569. Inclusion in this directory is not an endorsement.